Perini DuriganÁde Paula SimoniMBragaN, et al. Evolution of surgery for chronic subdural hematoma: a narrative review. Ann Med Surg (Lond). 2025;87:4139-4144.
2.
AtefiNAlcockSSilvaggioJAShankarJ.Clinical outcome and recurrence risk of chronic subdural hematoma after surgical drainage. Cureus. 2023;15:e35525.
3.
EdlmannEGiorgi-CollSWhitfieldPCCarpenterKLHutchinsonPJ.Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 2017;14:108.
4.
HutchinsonPJEdlmannEBultersD, et al. Trial of dexamethasone for chronic subdural hematoma. N Engl J Med. 2020;383:2616-2627.
5.
MandaiSSakuraiMMatsumotoY.Middle meningeal artery embolization for refractory chronic subdural hematoma. Case report. J Neurosurg. 2000;93:686-688.
6.
DaviesJMKnopmanJMokinM, et al. Adjunctive middle meningeal artery embolization for subdural hematoma. N Engl J Med. 2024;391:1890-1900.
7.
FiorellaDMonteithSJHanelR, et al. Embolization of the middle meningeal artery for chronic subdural hematoma. N Engl J Med. 2025;392(9):855-864.
8.
ShankarJJS. Embolization of middle meningeal artery for subdural hematoma in Canada (EMMA-CAN)-a randomized control trial. Int J Stroke. 2025;20(2_suppl):10.
9.
GeevargheseRCornelisFH. From innovation to paradigm shift: forecasting global trends in middle meningeal artery embolization. Can Assoc Radiol J. doi:10.1177/08465371251390860